These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2077415)

  • 1. Acute hyperuricemic nephropathy and renal failure after transplantation.
    Venkataseshan VS; Feingold R; Dikman S; Churg J
    Nephron; 1990; 56(3):317-21. PubMed ID: 2077415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between serum uric acid levels at 3 months after renal transplantation and the graft outcome in living donor renal transplantation.
    Choi JY; Kwon OJ
    Transplant Proc; 2013 May; 45(4):1548-52. PubMed ID: 23726617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M; Ikegami M; Ishii T; Nishioka T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
    Hinyokika Kiyo; 1990 Aug; 36(8):893-6. PubMed ID: 2239590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced kidney failure and hyperuricemia.
    Murea M
    Adv Chronic Kidney Dis; 2012 Nov; 19(6):419-24. PubMed ID: 23089278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal handling of uric acid under cyclosporin A treatment.
    Hoyer PF; Lee IJ; Oemar BS; Krohn HP; Offner G; Brodehl J
    Pediatr Nephrol; 1988 Jan; 2(1):18-21. PubMed ID: 3152994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hyperuricemic nephropathy in rats. An electron microscopic study.
    Waisman J; Mwasi LM; Bluestone R; Klinenberg JR
    Am J Pathol; 1975 Nov; 81(2):367-78. PubMed ID: 1190294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperuricemic nephropathies.
    Steele TH
    Nephron; 1999; 81 Suppl 1():45-9. PubMed ID: 9873214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of oxalate deposition in a renal transplant during ciclosporin A therapy.
    Drachman R; Dollberg L; Drukker A
    Child Nephrol Urol; 1988-1989; 9(1-2):90-2. PubMed ID: 3075154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of living-related renal transplant from the donor with membranous nephropathy.
    Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
    Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic experimental hyperuricemic nephropathy.
    Bluestone R; Waisman J; Klinenberg JR
    Lab Invest; 1975 Sep; 33(3):273-9. PubMed ID: 1160348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hyperuricemic nephropathy.
    Reiter L; Brown MA; Edmonds J
    Am J Kidney Dis; 1995 Feb; 25(2):235-41. PubMed ID: 7847350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal lesions in ciclosporin A-treated kidney transplant patients.
    Banfi G; Imbasciati E; Fogazzi GB; Tarantino A
    Appl Pathol; 1987; 5(2):95-100. PubMed ID: 3307851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial.
    Hart A; Jackson S; Kasiske BL; Mauer MS; Najafian B; Matas AJ; Spong R; Ibrahim HN
    Transplantation; 2014 May; 97(10):1066-71. PubMed ID: 24503762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation.
    Lesne M; Squifflet JP; Wallemacq P; Lenain F; Alexandre G
    Chemioterapia; 1985 Oct; 4(5):400-5. PubMed ID: 3907864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?
    Akgul A; Bilgic A; Ibis A; Ozdemir FN; Arat Z; Haberal M
    Transplant Proc; 2007 May; 39(4):1023-6. PubMed ID: 17524881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperuricemia and gout in cyclosporin A-treated renal transplant recipients.
    Lin HY; Rocher LL; McQuillan MA; Palella TD; Fox IH
    Adv Exp Med Biol; 1989; 253A():289-92. PubMed ID: 2624205
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of elevated serum uric acid on cisplatin-induced acute renal failure.
    Roncal CA; Mu W; Croker B; Reungjui S; Ouyang X; Tabah-Fisch I; Johnson RJ; Ejaz AA
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F116-22. PubMed ID: 17210794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histology of kidney transplant failure: a long-term follow-up study.
    Naesens M; Kuypers DR; De Vusser K; Evenepoel P; Claes K; Bammens B; Meijers B; Sprangers B; Pirenne J; Monbaliu D; Jochmans I; Lerut E
    Transplantation; 2014 Aug; 98(4):427-35. PubMed ID: 25243513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.